Shareholding disclosure

OSI Pharmaceuticals, Inc

Declared position

3.002%

Threshold

Crossed upwards

Timeline

Published

27.08.2009

Transaction

21.08.2009

Transfer date

21.08.2009

Voting rights breakdown

Voting rights acquired3.002%
Voting rights sold0%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TA98P00017

Beneficial owner

OSI Pharmaceuticals, Inc

Declared address

OSI Pharmaceuticals, Inc., Melville, NY 11747

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open